Gülistan Karadeniz1, Serir Aktoğu1, Onur Fevzi Erer1, Serpil Bulaç Kır2, Sibel Doruk2, Melike Demir3, Kübra Sonat4. 1. Dr Suat Seren Chest Disease & Surgery Training & Research Hospital, Department of Pulmonology, Izmir, Turkey. 2. Sifa University School of Medicine, Department of Pulmonology, Izmir, Turkey. 3. Dicle University School of Medicine, Department of Pulmonology, Diyarbakır, Turkey. 4. Dokuz Eylul University Faculty of Health Sciences, Department of Nursing, Izmir, Turkey.
Abstract
AIM: We aimed to assess the platelet-to-lymphocyte ratio (PLR) and platelet parameters in patients with chronic obstructive pulmonary disease (COPD). METHODS: A total of 60 stable COPD patients, 50 acute exacerbation COPD patients and 50 healthy controls were enrolled in this study. RESULTS: The platelet distribution width and PLR were higher and the mean platelet volume was lower in the COPD patients during acute exacerbation compared with the stable patients and controls. The PLR was negatively correlated with the forced expiratory volume in 1 s. CONCLUSION: The PLR may be used as a useful and easily accessible tool for evaluating the ongoing inflammation during stable period and the disease severity during acute exacerbations in COPD patients.
AIM: We aimed to assess the platelet-to-lymphocyte ratio (PLR) and platelet parameters in patients with chronic obstructive pulmonary disease (COPD). METHODS: A total of 60 stable COPDpatients, 50 acute exacerbation COPDpatients and 50 healthy controls were enrolled in this study. RESULTS: The platelet distribution width and PLR were higher and the mean platelet volume was lower in the COPDpatients during acute exacerbation compared with the stable patients and controls. The PLR was negatively correlated with the forced expiratory volume in 1 s. CONCLUSION: The PLR may be used as a useful and easily accessible tool for evaluating the ongoing inflammation during stable period and the disease severity during acute exacerbations in COPDpatients.
Entities:
Keywords:
chronic obstructive pulmonary disease; mean platelet volume; platelet-to-lymphocyte ratio